Eli Lilly’s (LLY) Shares Up Since Jim Cramer Said He Was a Long Term Believer

Eli Lilly and Company (NYSE:LLY) is one of Jim Cramer’s Hottest GLP-1 and Weight Loss Stock Picks. Eli Lilly and Company (NYSE:LLY) is the premier player in the weight loss drug industry. Its shares are up by 6% over the past year and by 21% since Cramer discussed them in January 2025. They closed 8% higher on October 1st, on the day it surfaced that the Trump administration would give pharmaceutical giant Pfizer a three-year grace from tariffs. Eli Lilly and Company (NYSE:LLY)’s shares then proceeded to ...